Enhancing the Value of Population-Based Risk Scores for Institutional-Level Use

被引:3
|
作者
Raza, Sajjad
Sabik, Joseph F., III
Rajeswaran, Jeevanantham
Idrees, Jay J.
Trezzi, Matteo
Riaz, Haris
Javadikasgari, Hoda
Nowicki, Edward R.
Svensson, Lars G.
Blackstone, Eugene H.
机构
[1] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Inst Heart & Vasc, Dept Quantitat Hlth Sci,Res Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Internal Med, Inst Med, Cleveland, OH 44195 USA
来源
ANNALS OF THORACIC SURGERY | 2016年 / 102卷 / 01期
关键词
AORTIC-VALVE-REPLACEMENT; CARDIAC-SURGERY; SURGICAL RISK; MORTALITY; MODELS; MORBIDITY; OUTCOMES; SOCIETY; REOPERATION; TRANSFUSION;
D O I
10.1016/j.athoracsur.2015.12.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. We hypothesized that factors associated with an institution's residual risk unaccounted for by population-based models may be identifiable and used to enhance the value of population-based risk scores for quality improvement. Methods. From January 2000 to January 2010, 4,971 patients underwent aortic valve replacement (AVR), either isolated (n = 2,660) or with concomitant coronary artery bypass grafting (AVR+CABG; n = 2,311). Operative mortality and major morbidity and mortality predicted by The Society of Thoracic Surgeons (STS) risk models were compared with observed values. After adjusting for patients' STS score, additional and refined risk factors were sought to explain residual risk. Differences between STS model coefficients (risk-factor strength) and those specific to our institution were calculated. Results. Observed operative mortality was less than predicted for AVR (1.6% [42 of 2,660] vs 2.8%, p < 0.0001) and AVR+CABG (2.6% [59 of 2,311] vs 4.9%, p < 0.0001). Observed major morbidity and mortality was also lower than predicted for isolated AVR (14.6% [389 of 2,660] vs 17.5%, p < 0.0001) and AVR+CABG (20.0% [462 of 2,311] vs 25.8%, p < 0.0001). Shorter height, higher bilirubin, and lower albumin were identified as additional institution-specific risk factors, and body surface area, creatinine, glomerular filtration rate, blood urea nitrogen, and heart failure across all levels of functional class were identified as refined risk-factor variables associated with residual risk. In many instances, risk-factor strength differed substantially from that of STS models. Conclusions. Scores derived from population-based models can be enhanced for institutional level use by adjusting for institution-specific additional and refined risk factors. Identifying these and measuring differences in institution-specific versus population-based risk-factor strength can identify areas to target for quality improvement initiatives. (C) 2016 by The Society of Thoracic Surgeons
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [41] Zopiclone Use and Risk of Fractures in Older People: Population-Based Study
    Nishtala, Prasad S.
    Chyou, Te-yuan
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2017, 18 (04) : 368.e1 - 368.e8
  • [42] Statin use and prostate cancer risk in a large population-based setting
    Denise M. Boudreau
    Onchee Yu
    Diana S. M. Buist
    Diana L. Miglioretti
    Cancer Causes & Control, 2008, 19 : 767 - 774
  • [43] Triptan Use as a Function of Cardiovascular Risk. A Population-Based Study
    Bigal, Marcelo E.
    Golden, Wendy
    Buse, Dawn
    Chen, Ya-Ting
    Lipton, Richard B.
    HEADACHE, 2010, 50 (02): : 256 - 263
  • [44] Sunscreen Use and Subsequent Melanoma Risk: A Population-Based Cohort Study
    Ghiasvand, Reza
    Weiderpass, Elisabete
    Green, Adele C.
    Lund, Eiliv
    Veierod, Marit B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (33) : 3976 - U70
  • [45] Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study
    Reed, B. D.
    Harlow, S. D.
    Legocki, L. J.
    Helmuth, M. E.
    Haefner, H. K.
    Gillespie, B. W.
    Sen, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (13) : 1678 - 1684
  • [46] Use of Bisphosphonate and Risk of Incident Atrial Fibrillation in a Population-Based Study
    Sheehy, Shanshan
    Peloquin, Christine
    Neogi, Tuhina
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] Statin use and breast cancer risk in a large population-based setting
    Boudreau, Denise M.
    Yu, Onchee
    Miglioretti, Diana L.
    Buist, Diana S. M.
    Heckbert, Susan R.
    Daling, Janet R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (03) : 416 - 421
  • [48] Statin Use Is Associated With a Lower Risk of Blepharitis: A Population-Based Study
    Feng, Kathy Ming
    Chung, Chi-Hsiang
    Chen, Yi-Hao
    Chien, Wu-Chien
    Chien, Ke-Hung
    FRONTIERS IN MEDICINE, 2022, 9
  • [49] Statin use and prostate cancer risk in a large population-based setting
    Boudreau, Denise M.
    Yu, Onchee
    Buist, Diana S. M.
    Miglioretti, Diana L.
    CANCER CAUSES & CONTROL, 2008, 19 (07) : 767 - 774
  • [50] Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study
    Koh, Ji Weon
    Kim, Junkang
    Cho, Hyemin
    Ha, Yong-Chan
    Kim, Tae-Young
    Lee, Young-Kyun
    Kim, Ha Young
    Jang, Sunmee
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 562 - 570